Overview
Archer Review provides online test-prep resources for healthcare students and professionals. Its platform offers subscription access to a large NCLEX-style Q-Bank, on-demand video lectures, and live reviews, using Computerized Adaptive Testing and readiness assessments to simulate real exams. It differentiates itself by affordable pricing, bundled packages like Sure Pass, and structured options such as six-week boot camps and one-on-one tutoring, plus a Nursing School companion aligning with curricula. Its goal is to expand access to licensure and certification prep as part of a broader healthcare education platform after its 2024 acquisition by Leeds Equity Partners and leadership transition under CEO Dr. Tabatha Erck.
Work here?Claim your company
Simplify's take
What believers are saying
- Archer says 138,000 students used NCLEX prep in 2026, sustaining demand.
- Archer reports 98.98% NCLEX pass rates for high-readiness users, strengthening conversion.
- OnlineMedEd adds 300,000 medical learners, expanding Archer beyond nursing into medical schools.
What critics are saying
- Archer's 52.7% usage and 98.98% pass-rate claims rely on internal self-reported data.
- Integrating OnlineMedEd, PulsedIn, and Core Anesthesia risks product overlap and culture clashes by 2027.
- A weaker NCLEX format advantage or competitor pricing war crushes Archer's Sure PASS franchise by 2027.
What makes Archer Review unique
- Archer Review combines NCLEX adaptive testing with OnlineMedEd's clinical curriculum after March 2025.
- Its 2025 acquisitions added PulsedIn and Core Anesthesia, widening healthcare exam coverage.
- Tabatha Erck's 2025 leadership and Leeds Equity backing accelerate cross-credential platform building.
Help us improve and share your feedback! Did you find this helpful?